VERMIDOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vermidol, and what generic alternatives are available?
Vermidol is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in VERMIDOL is piperazine citrate. There are eighteen drug master file entries for this compound. Additional details are available on the piperazine citrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VERMIDOL?
- What are the global sales for VERMIDOL?
- What is Average Wholesale Price for VERMIDOL?
Summary for VERMIDOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 45 |
| DailyMed Link: | VERMIDOL at DailyMed |
US Patents and Regulatory Information for VERMIDOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | VERMIDOL | piperazine citrate | SYRUP;ORAL | 080992-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
